Introduction
Alpha-fetoprotein (AFP) is a fetal serum protein produced by fetal liver and yolk sac cells, and by some fetal gastrointestinal cells [1] . After birth, the level of the protein in serum rapidly decreases. However, its level is elevated in patients with hepatocellular carcinoma and in those with noncancerous liver diseases associated with liver regeneration, such as cirrhosis and hepatitis [2] [3] [4] [5] [6] . Recently, AFP-producing tumors have been reported in several different organs [7] [8] [9] [10] [11] [12] [13] , with gastric adenocarcinoma being one of the most common of these tumors [14] . Since the first report of AFPproducing gastric carcinoma by Bourreille et al. [15] , other cases have been described, and the incidence is reported to be 1.3%-15% of all gastric carcinomas [16] [17] [18] [19] [20] . Kodama et al. [21] described two histologic types of AFP-producing gastric carcinoma. Later, Ishikura et al. [22, 23] proposed the term "hepatoid adenocarcinoma of the stomach" for primary gastric carcinomas that are characterized by both hepatoid differentiation and the production of large amounts of AFP. This type of tumor is a relatively rare gastric carcinoma, and is recognized as having a poor prognosis, even if the tumor is diagnosed at an early stage [24] . In this report, we describe a rare case of hepatoid adenocarcinoma of the stomach, with a review of the literature and investigation of the clinical features.
Case report
A 67-year-old Japanese man consulted a local doctor because of a 2-month history of general fatigue. Upper gastrointestinal radiological studies suggested gastric cancer (Fig. 1A) . He was referred to our hospital on February 9, 2000, for further examination. His medical history included hypertension and diabetes.
On physical examination, anemic conjunctiva was detected. Results of the physical examinations were unremarkable. Hematological investigations revealed anemia (hemoglobin [Hb], 7.6 g/dl; hematocrit [Ht], 26.2%). Results of other laboratory tests, including liver function tests, were all within normal limits. The serum level of AFP was elevated (10 084 ng/ml), but the levels of carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) were within normal limits. Hepatitis B surface antigen and antibody, and hepatitis C antibody, were all negative. Endoscopy (Fig. 1B) revealed an elevated tumor, with foci of necrosis and hemorrhage, at the lesser curvature, extending from the antrum to the body of the stomach. The tumor was classified macroscopically as type 5, according to the general rules of the Japanese Gastric Cancer Association (JGCA) [25] . Gastric biopsy revealed moderatelyto-poorly differentiated adenocarcinoma. Abdominal computed tomography (CT) scan, ultrasonography, and magnetic resonance imaging (MRI) showed thickening of the posterior wall of the stomach, lymph node swelling around the left gastric artery and common hepatic artery, and a 7.0-cm cyst in the upper pole of the right kidney. Tumor infiltration to the pancreas was not evident. Multiple solid lesions, highly suggestive of metastasis from gastric cancer, were revealed in the liver (Fig. 2) , but no cirrhotic change was observed. A diagnosis of AFP-producing gastric cancer with multiple liver metastases was made, and total gastrectomy with lymph node dissection was performed, on February 18, 2000.
At the operation, neither fibrotic change nor cirrhosis was seen in the liver. Because of the multiple metastases, liver resection was not performed. The surgically resected specimen showed an elevated tumor, 8.5 cm in maximal diameter, with central ulceration and surface erosion, involving the antrum and body, from the lesser curvature to the posterior-wall. There was a polypoid tumorous component in the posterior-wall side of the lesion (Fig. 3A) . The tumor was classified as type 5, according to the general rules of the JGCA. The cut surface showed a slightly grayish-white tumor infiltrating to at least the muscularis propria (Fig. 3B) . Areas of coagulation necrosis were seen in the tumor. Grossly, the remainder of the resected stomach appeared unremarkable. Three lymph nodes on the lesser curvature and one lymph node on the greater curvature showed massive swelling. Light microscopic examination showed that tumor invasion was mainly limited to the area from the mucosa to the proper muscle layer, although invasion to the subserosal layer was evident in some areas. The tumor showed three types of histology. The major part, composed of large polygonal cells with abundant eosinophilic cytoplasm separated by fibrous stroma, arranged in a trabecular pattern, resembled moderately differentiated hepatocellular carcinoma (Fig. 4A) . One of the other parts showed moderately differentiated fetal-type adenocarcinoma with clear cell foci, and also showed large-cell transformation (Fig. 4B) , while an area of common-type adenocarcinoma was seen in less than 10% of the whole tumor. Coagulation necrosis was seen in many areas of the tumor nodules. Prominent intravascular proliferation of hepatoid tumor cells, which sometimes formed tumor thrombi, was frequently observed. Neither a reticular pattern nor Schiller-Duval bodies were found in the tumor. Occasional cells in both the hepatoid and fetal-type components had intracytoplasmic hyaline globules, which were stained with PAS and resistant to diastase digestion. Despite further detailed study by light microscopy, bile secretion was not observed. Immunohistochemistry showed that both the hepatocellular carcinoma-like cells and fetal-type adenocarcinoma cells were diffusely positive for AFP (Fig.  5) . Furthermore, alpha-1 antitrypsin (AAT) and alpha-1 antichymotripsin (ACT) were focally positive in the hepatoid areas. Specific staining for CEA was focally demonstrated in the peripheral adenocarcinomatous area. Ki-67 expression in the tumor cell nuclei was markedly elevated (Ki-67 labeling index, 60.2%). On the basis of these pathologic and immunohistochemical findings, the tumor was diagnosed as hepatoid adenocarcinoma of the stomach. There were cancer metastases in 4 of the 73 lymph nodes histologically examined from the lesser curvature and near the common hepatic artery. The tumor was diagnosed as stage IV (ss, ly2, v3, n2, H1, M0) according to the general rules of the JGCA [25] .
Postoperatively, anastomotic leakage occurred at the esophagojejunostomy site, but it was controlled by the injection of fibrin adhesive into the area surrounding the anastomosis. The patient was then treated orally with an anticancer drug (1 M tegafur-0.4 M gimestat-1 M ostat potassium, TS-1). Although the serum AFP level decreased to 6.2 ng/ml within 2 months, it has increased again to 22.5 ng/ml. Careful follow-up of this patient has revealed growth of the liver metastases, but the patient remains alive 11 months after the operation.
Discussion
AFP is an oncofetal glycoprotein produced mainly in the fetal liver and the yolk sac and, to a small extent, in the fetal gastrointestinal tract [1] . The highest serum levels occur between weeks 12 and 15 of gestation. After birth, the protein level in the serum rapidly decreases. However, under pathologic conditions, AFP is detected in the serum of adults with hepatocellular carcinoma, those with yolk sac tumors, and those with noncancerous liver disease associated with liver regeneration, such as cirrhosis and hepatitis [2] [3] [4] [5] [6] . AFPProducing malignant tumors have been reported in several organs; for example, the lung [7, 8] , pancreas [9, 10] , Macroscopic type and the depth are according to the Japanese classification of gastric carcinoma [25] NA, details not available; BW, body weight; U, upper-third portion; M, middle-third portion; L, lower-third portion; U 1 , remnant stomach; TG, total gastrectomy; STG, subtotal gastrectomy; DG, distal gastrectomy; PG, partial gastrectomy; GR, gastric resection; LR, liver resection; li, liver; ln, lymph nodes; lu, lung; p, peritoneum; panc, pancreas; om, omentum; 5-FU, 5-fluorouracil; MMC, mitomycin C; ADM, adriamycin; AFP, alpha-fetoprotein; PIVKA-II, des-γ-carboxy prothrombin; CEA, carcinoembryonic antigen; CA 19-9, carbohydrate artigen 19-9; TS-1, 1M tegafur-0.4 M gimestat-1 M ostat potassium; CDDP, cisplatin; 5'DFUR, 5Ј-deoxy-5-fluorouridine; UFT, tegafur uracil; rad 1 , intraoperative radiation therapy; rad 2 , postoperative radiation therapy; died, died of the disease colon [11] , bladder [12] , and ovary [13] . The stomach is one of the most common sites affected by these tumors, and the first such case was described by Bourreille et al. in 1970 [15] . The reported incidence of AFP-producing gastric carcinoma has been 1.3%-15% of all gastric carcinomas [16] [17] [18] [19] [20] . Kodama et al. [21] described two histologic types of AFP-producing gastric carcinoma, based on immunohistochemical staining; a medullary type, characterized by polygonal cells arranged in solid nests or sheets, with scattered large pleomorphic or multinucleated giant cells, and a well differentiated papillary or tubular type with clear cytoplasm. The two types sometimes coexisted in a single tumor. Ishikura et al. [22, 23] proposed the term "hepatoid adenocarcinoma of the stomach" for primary gastric carcinomas characterized histologically by hepatoid differentiation and the production of large amounts of AFP. Motoyama et al. [26] reported that hepatoid adenocarcinoma was the most frequently observed histological type of AFP-producing gastric cancer. To discriminate between hepatoid adenocarcinoma and nonhepatoid adenocarcinoma of the stomach, the measurement of AFP isoforms is also useful, and the AFP level in the serum of patients with hepatoid adenocarcinona shows a liver-type binding pattern with the lectin concanavalin A (Con-A) [23] . However, Ooi et al. [27] reported that this was not significant, because such a liver-type binding pattern was detected in only 20% of AFP-producing tumors.
On the other hand, Nagai et al. [28] noted that the diagnosis of hepatoid adenocarcinoma of the stomach was not dependent on whether AFP was produced, and considered that diagnosis was better based on the recognition of the characteristic histologic features. They reported that the presence of PAS-positive and diastase-resistant intracytoplasmic eosinophilic globules, and immunohistochemical positivity for AAT, ACT, and bile (which is shown in hepatocellular carcinoma) supported the diagnosis, even though these findings were nonspecific.
Furthermore, there is sometimes confusion about whether hepatoid carcinoma originates from the stomach or the liver, because most patients show multiple liver metastasis preoperatively. Our patient's tumor was believed to have originated from hepatoid adenocarcinoma of the stomach, because his serum AFP level decreased rapidly after gastrectomy (although this level has again been increasing) and the liver tumor was not resected. This rapid decrease was probably due to mass reduction by surgery, while the postoperative chemotherapy with TS-1 may be relatively effective for the suppression of tumor growth. Furthermore, although the size of the liver tumors has increased, the patient's serum CEA level was not increased just before and after surgery. Additionally, most primary liver cancers in Japan have a background of cirrhosis or fibrosis in the noncancerous portion of the liver [29] . However, our patient was negative for hepatitis B surface antigen and antibody, and for hepatitis C antibody, and no cirrhosis or fibrosis was seen in the noncancerous part of the liver.
In the literature, 85 cases described by the term "hepatoid adenocarcinoma of the stomach" have been reported, including the present case (Table 1 [22, 23, 24, 26, 28, ). The average age of the patients was 63.5 years (range, 44-87 years), and the male-to-female ratio was 58 : 25 (the sex was not stated for 2 patients). In most of these patients, the tumors occurred mainly at the antrum (60.2%). The average serum AFP level was 51 130.1 ng/ml (range, less than 1.0-700 000 ng/ml); that is, much higher than normal. Although there were no major symptoms sufficient to allow diagnosis of this type of cancer, epigastric pain and general fatigue, because of anemia, were the most common symptoms. The average maximal tumor diameter was 6.5 cm (range, 1.6-14.0 cm). Early-stage cancer was seen in In addition, coagulation necrosis was frequently observed. In most of the reported patients, metastases to the liver and/or lymph nodes were detected preoperatively. Bile secretion was reported in only 4 patients, whereas this is a common feature in hepatocellular carcinoma. Furthermore, most of the patients died within 2 years of surgery, despite systemic chemotherapy having been administered in several patients. These reports suggest that even earlystage hepatoid adenocarcinoma has an extremely poor prognosis, because of the frequent occurrence of liver and/or lymph node metastases [24, 26, 28] . However, the reasons for the poor prognosis are not clearly understood. Nagai et al. [28] reported that hepatoid adenocarcinoma had a poor prognosis compared with that for AFP-producing nonhepatoid adenocarcinoma. One possibility is that hepatoid adenocarcinoma produces AAT and/or ACT as well as AFP. AAT and ACT have immunosuppressive and protease-inhibitory properties that enhance invasiveness [63, 64] . Also, AFP has a suppressive effect on lymphocyte transformation [65] . In addition, Koide et al. [66] have reported that AFP-producing gastric cancer has high proliferative activity, weak apoptosis, and rich neovascularization. Compared with findings in previous reports [66, 67] , Ki-67 expression-which is associated with proliferative activity and tumor progression [68] was extremely marked in our patient. Furthermore, these tumors are known to be resistant to chemotherapy [69] .
Because of the extremely poor prognosis of hepatoid adenocarcinoma of the stomach, it is important to ensure that the diagnosis is accurate. Furthermore, as Chang et al. [24] have reported, even if no metastasis is present preoperatively, liver metastasis can occur within a year after surgery, and, thus, close observation and long-term follow-up of patients are required. However, several patients for whom chemotherapy was effective have been reported [34, 38, 60, 62] . Therefore, even if hepatoid adenocarcinoma is diagnosed, curative resection and further chemotherapy are recommended.
